Key facts
- Nanodrops’s last known valuation is $9.1M (Jan 2025).
- It has raised $3.6M; the latest was Later Stage VC ($3.0M) in Jan 2025.
- Notable investors include Sanara Capital.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Nanodrops
- ·The full record, as it builds
Funding rounds
No funding rounds for Nanodrops are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Nanodrops
Developer of vision correction technology intended for correcting refractive errors. The company's platform uses a minimally invasive, laser-assisted pattern on the cornea and instills nanoparticles to locally modify the corneal refractive index, which is reversible and repeatable, enabling patients to customize their visual acuity without the need for glasses or contact lenses as their vision needs evolve.
- Sector
- Healthcare
- HQ
- Or Yehuda, Israel
- Founded
- 2018
- Website
- nano-drops.com/
- Ownership
- Privately Held (backing)
Nanodrops doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Nanodrops shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Nanodrops in its N-PORT filings yet. We sweep new filings monthly.